Role of APOE and Age at Enrollment in the Alzheimer’s Disease Anti-Inflammatory Prevention Trial (ADAPT)

Publisher： Karger

E-ISSN： 1664-5464|2|1|304-311

ISSN： 1664-5464

Source： Dementia and Geriatric Cognitive Disorders Extra, Vol.2, Iss.1, 2012-08, pp. : 304-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review

By  

Neuroepidemiology, Vol. 23, Iss. 4, 2004-07 ,pp. : 159-169

Karger

Access to resources Recommend Favorite

APOE Genotype and Alzheimer´s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 4, 2000-06 ,pp. : 237-237

Karger

Access to resources Recommend Favorite

A Case-Control Analysis of Nonsteroidal Anti-Inflammatory Drugs and Alzheimer’s Disease: Are They Protective?

By  

Neuroepidemiology, Vol. 21, Iss. 2, 2002-03 ,pp. : 81-86

Karger

Access to resources Recommend Favorite

Pattern and Progression of Cognitive Decline in Alzheimer’s Disease: Role of Premorbid Intelligence and ApoE Genotype

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 6, 2007-11 ,pp. : 483-491

Karger

Access to resources Recommend Favorite

Patterns of Cortical Thickness according to APOE Genotype in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 5, 2009-11 ,pp. : 461-470

Karger

Access to resources Recommend Favorite